BACITRACIN

BACITRACIN was reported 3752 times

BACITRACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UNWANTED AWARENESS DURING ANAESTHESIA 31 0.0945
1 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
2 BANDAEMIA 3 0.0204
3 DEAFNESS PERMANENT 4 0.0204
4 LYMPHATIC DISORDER 8 0.0134
5 CAUSTIC INJURY 4 0.0128
6 NEONATAL RESPIRATORY DEPRESSION 4 0.0120
7 TRACHEITIS 7 0.0092
8 CORNEAL ABRASION 12 0.0087
9 CARBON DIOXIDE DECREASED 10 0.0087
10 MEAN PLATELET VOLUME INCREASED 5 0.0083
11 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 8 0.0075
12 NAIL DYSTROPHY 4 0.0071
13 OPHTHALMIC HERPES SIMPLEX 4 0.0069
14 SLOW RESPONSE TO STIMULI 9 0.0069
15 CRYSTAL NEPHROPATHY 4 0.0068
16 EXTRADURAL ABSCESS 5 0.0064
17 ENDOCRINE OPHTHALMOPATHY 5 0.0058
18 DERMATITIS DIAPER 4 0.0057
19 VENOUS INSUFFICIENCY 4 0.0055
20 PRIMARY SEQUESTRUM 5 0.0055
21 CORNEAL OPACITY 7 0.0051
22 PERIORBITAL PAIN 4 0.0047
23 BLOOD CHLORIDE INCREASED 8 0.0046
24 OSTEOSCLEROSIS 7 0.0044
25 NEPHROGENIC ANAEMIA 19 0.0041
26 HYPERPARATHYROIDISM SECONDARY 10 0.0040
27 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0040
28 LEFT ATRIAL DILATATION 5 0.0039
29 NEUROGENIC BLADDER 8 0.0038
30 CARBON DIOXIDE INCREASED 5 0.0037
31 LUMBAR RADICULOPATHY 4 0.0035
32 SEBORRHOEIC KERATOSIS 5 0.0034
33 RECTAL ULCER 4 0.0034
34 CHRONIC RESPIRATORY FAILURE 4 0.0033
35 REBOUND ACID HYPERSECRETION 10 0.0033
36 BLOOD UREA DECREASED 4 0.0032
37 HYPERAESTHESIA TEETH 4 0.0032
38 TESTICULAR SWELLING 4 0.0032
39 ACTINOMYCOSIS 3 0.0031
40 RHONCHI 4 0.0029
41 BLOOD BLISTER 9 0.0029
42 GENITAL RASH 4 0.0028
43 NAIL INFECTION 4 0.0028
44 PUPILLARY REFLEX IMPAIRED 5 0.0027
45 CLOSTRIDIAL INFECTION 9 0.0027
46 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
47 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
48 METABOLIC ALKALOSIS 4 0.0025
49 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
50 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 6 0.0023
51 NECROTISING FASCIITIS 8 0.0023
52 MITRAL VALVE DISEASE 4 0.0023
53 LARYNGOSPASM 6 0.0022
54 FACIAL BONES FRACTURE 8 0.0022
55 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
56 ULCERATIVE KERATITIS 6 0.0022
57 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
58 INGROWING NAIL 5 0.0021
59 MYELOPATHY 4 0.0021
60 NASAL SEPTUM DEVIATION 4 0.0020
61 DERMAL CYST 5 0.0020
62 HYPERNATRAEMIA 10 0.0020
63 METABOLIC ENCEPHALOPATHY 6 0.0020
64 HYPERCAPNIA 6 0.0020
65 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
66 BACTERIAL VAGINOSIS 3 0.0019
67 BLOOD CREATININE DECREASED 6 0.0019
68 DILATATION VENTRICULAR 4 0.0019
69 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
70 ACUTE LEUKAEMIA 3 0.0019
71 CARDIAC MURMUR 16 0.0018
72 ERYTHEMA OF EYELID 10 0.0018
73 EXPOSED BONE IN JAW 4 0.0018
74 ORAL FUNGAL INFECTION 5 0.0018
75 CORNEAL DISORDER 4 0.0018
76 BLOOD CALCIUM ABNORMAL 3 0.0018
77 MULTI-ORGAN FAILURE 31 0.0018
78 WOUND DEHISCENCE 6 0.0018
79 CANDIDIASIS 7 0.0017
80 BLEPHARITIS 7 0.0017
81 PERIPHERAL ISCHAEMIA 7 0.0017
82 EMBOLIC STROKE 6 0.0017
83 HAEMORRHAGIC DIATHESIS 6 0.0017
84 ATELECTASIS 16 0.0017
85 ORAL INTAKE REDUCED 4 0.0017
86 BRONCHITIS CHRONIC 4 0.0016
87 CHEST X-RAY ABNORMAL 5 0.0016
88 SPINAL OSTEOARTHRITIS 14 0.0016
89 END STAGE RENAL DISEASE 29 0.0016
90 KLEBSIELLA INFECTION 8 0.0016
91 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
92 ACIDOSIS 12 0.0016
93 CLAVICLE FRACTURE 6 0.0016
94 HEPATOSPLENOMEGALY 4 0.0016
95 INCREASED UPPER AIRWAY SECRETION 8 0.0016
96 AORTIC ARTERIOSCLEROSIS 4 0.0016
97 SPINAL CORD COMPRESSION 6 0.0015
98 FACET JOINT SYNDROME 5 0.0015
99 ANHEDONIA 40 0.0015
100 OTITIS MEDIA 5 0.0015
101 MENTAL STATUS CHANGES 42 0.0015
102 GANGRENE 9 0.0015
103 DERMATITIS CONTACT 17 0.0015
104 METASTASES TO SPINE 5 0.0015
105 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
106 SKIN ABRASION 7 0.0015
107 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
108 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
109 CROHN'S DISEASE 10 0.0015
110 LUNG CONSOLIDATION 4 0.0014
111 RENAL TUBULAR NECROSIS 14 0.0014
112 PURULENT DISCHARGE 6 0.0014
113 APPLICATION SITE SWELLING 7 0.0014
114 LIP PAIN 4 0.0014
115 UPPER RESPIRATORY TRACT CONGESTION 4 0.0014
116 PULMONARY FUNCTION TEST DECREASED 6 0.0014
117 MELANOCYTIC NAEVUS 6 0.0014
118 BLOOD PHOSPHORUS DECREASED 5 0.0014
119 ONYCHOMYCOSIS 6 0.0014
120 TOOTH DISCOLOURATION 4 0.0014
121 ABDOMINAL ABSCESS 6 0.0014
122 CHRONIC SINUSITIS 5 0.0013
123 OCULAR HYPERAEMIA 63 0.0013
124 SQUAMOUS CELL CARCINOMA OF SKIN 8 0.0013
125 OSTEOPENIA 20 0.0013
126 FACE INJURY 5 0.0013
127 EYE INJURY 4 0.0013
128 EYELIDS PRURITUS 4 0.0013
129 RENAL INJURY 38 0.0013
130 TESTICULAR PAIN 4 0.0013
131 TACHYPNOEA 17 0.0012
132 FAECAL INCONTINENCE 6 0.0012
133 CUSHINGOID 4 0.0012
134 LOOSE TOOTH 4 0.0012
135 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
136 HYPOXIA 43 0.0012
137 INJECTION SITE INFECTION 4 0.0012
138 ACUTE PSYCHOSIS 3 0.0012
139 CHRONIC KIDNEY DISEASE 92 0.0012
140 EYE SWELLING 45 0.0012
141 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
142 THERAPEUTIC AGENT TOXICITY 4 0.0012
143 POSTOPERATIVE WOUND INFECTION 8 0.0012
144 BACTERAEMIA 14 0.0012
145 ABSCESS LIMB 5 0.0012
146 PROTHROMBIN TIME PROLONGED 7 0.0012
147 BLOOD CHLORIDE DECREASED 3 0.0012
148 DIFFICULTY IN WALKING 4 0.0012
149 ACTINIC KERATOSIS 3 0.0012
150 FAILURE TO THRIVE 6 0.0012
151 EYE DISCHARGE 12 0.0012
152 ORAL CANDIDIASIS 15 0.0011
153 NASAL DISCOMFORT 9 0.0011
154 LUNG INFILTRATION 10 0.0011
155 PHYSICAL DISABILITY 5 0.0011
156 GENERALISED OEDEMA 14 0.0011
157 LUNG TRANSPLANT 4 0.0011
158 THERMAL BURN 8 0.0011
159 DIVERTICULUM 8 0.0011
160 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
161 EYELID OEDEMA 13 0.0011
162 FEAR 30 0.0011
163 ANAL ABSCESS 6 0.0011
164 BONE LESION 4 0.0011
165 DECUBITUS ULCER 9 0.0011
166 VASCULAR DEVICE INFECTION 5 0.0011
167 BLOOD PHOSPHORUS INCREASED 3 0.0011
168 SPINAL COMPRESSION FRACTURE 9 0.0011
169 STEVENS-JOHNSON SYNDROME 24 0.0011
170 TENDON INJURY 4 0.0011
171 GASTRITIS EROSIVE 5 0.0011
172 NEPHROPATHY 10 0.0011
173 EYE INFECTION 12 0.0011
174 VAGINAL INFECTION 5 0.0011
175 PROTEIN TOTAL DECREASED 4 0.0011
176 STAPHYLOCOCCAL INFECTION 35 0.0011
177 SPINAL COLUMN STENOSIS 5 0.0011
178 PERONEAL NERVE PALSY 6 0.0011
179 PULSE ABSENT 5 0.0011
180 PSEUDOMONAS INFECTION 9 0.0010
181 ENTEROCOCCAL INFECTION 5 0.0010
182 PANIC DISORDER 4 0.0010
183 ORAL INFECTION 4 0.0010
184 ECCHYMOSIS 7 0.0010
185 DECREASED INTEREST 6 0.0010
186 EYE PRURITUS 34 0.0010
187 EXPIRED DRUG ADMINISTERED 5 0.0010
188 BLOOD ALBUMIN DECREASED 8 0.0010
189 WOUND INFECTION 11 0.0010
190 CEREBRAL ATROPHY 4 0.0010
191 AZOTAEMIA 4 0.0010
192 LOW TURNOVER OSTEOPATHY 4 0.0010
193 RHINITIS 8 0.0010
194 ECONOMIC PROBLEM 15 0.0010
195 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
196 PATHOLOGICAL FRACTURE 5 0.0010
197 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
198 PERIPHERAL VASCULAR DISORDER 5 0.0010
199 STOMACH DISCOMFORT 5 0.0010
200 MALABSORPTION 5 0.0010
201 NASAL DRYNESS 6 0.0010
202 PHOTOPHOBIA 18 0.0010
203 MOUTH HAEMORRHAGE 7 0.0010
204 HALLUCINATIONS, MIXED 4 0.0010
205 BRAIN OEDEMA 12 0.0009
206 BLADDER PAIN 3 0.0009
207 PHARYNGOLARYNGEAL PAIN 5 0.0009
208 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
209 SKIN HYPERPIGMENTATION 8 0.0009
210 METASTATIC NEOPLASM 4 0.0009
211 HIATUS HERNIA 12 0.0009
212 TOOTH INJURY 4 0.0009
213 SKIN LACERATION 10 0.0009
214 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
215 IMMOBILE 4 0.0009
216 HAEMORRHAGIC ANAEMIA 4 0.0009
217 CYSTIC FIBROSIS 5 0.0009
218 APNOEA 7 0.0009
219 RHINITIS ALLERGIC 4 0.0009
220 RENAL FAILURE 119 0.0009
221 CARDIOMEGALY 11 0.0009
222 SKIN INFECTION 10 0.0009
223 BLOOD CALCIUM DECREASED 10 0.0009
224 PHARYNGITIS 11 0.0009
225 EYE PAIN 50 0.0009
226 FURUNCLE 7 0.0009
227 TRICUSPID VALVE INCOMPETENCE 7 0.0009
228 PULMONARY MASS 13 0.0009
229 VISUAL DISTURBANCE 5 0.0009
230 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
231 HAIR GROWTH ABNORMAL 6 0.0009
232 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
233 HYPOPHAGIA 22 0.0009
234 RIGHT VENTRICULAR FAILURE 6 0.0009
235 HYPERTRIGLYCERIDAEMIA 5 0.0009
236 FLANK PAIN 8 0.0009
237 INCONTINENCE 9 0.0009
238 ARTERIOSCLEROSIS 8 0.0008
239 DEVICE RELATED INFECTION 13 0.0008
240 CARDIAC TAMPONADE 4 0.0008
241 SLEEP APNOEA SYNDROME 16 0.0008
242 HYPERLIPIDAEMIA 10 0.0008
243 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
244 HYPOVOLAEMIC SHOCK 4 0.0008
245 SUBCUTANEOUS ABSCESS 4 0.0008
246 ACUTE RESPIRATORY FAILURE 16 0.0008
247 APHAGIA 4 0.0008
248 TONGUE DISORDER 6 0.0008
249 LEUKOCYTOSIS 15 0.0008
250 EAR PAIN 16 0.0008
251 GASTROENTERITIS 12 0.0008
252 CELLULITIS 41 0.0008
253 BODY TEMPERATURE DECREASED 8 0.0008
254 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
255 LARYNGEAL OEDEMA 5 0.0008
256 BLOOD MAGNESIUM DECREASED 7 0.0008
257 PSYCHOLOGICAL TRAUMA 7 0.0008
258 SCOLIOSIS 5 0.0008
259 PROTEIN URINE PRESENT 4 0.0008
260 URINE OUTPUT DECREASED 7 0.0008
261 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
262 BLOOD POTASSIUM DECREASED 24 0.0008
263 PURPURA 7 0.0008
264 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
265 TOXIC ENCEPHALOPATHY 4 0.0008
266 TOOTH ABSCESS 8 0.0008
267 FOREIGN BODY SENSATION IN EYES 5 0.0008
268 EYE IRRITATION 45 0.0008
269 ENDOCARDITIS 4 0.0008
270 PRODUCT COLOUR ISSUE 4 0.0008
271 VARICOSE VEIN 4 0.0008
272 POOR QUALITY DRUG ADMINISTERED 5 0.0008
273 INCOHERENT 5 0.0008
274 MULTIPLE ALLERGIES 6 0.0008
275 RESPIRATORY DISTRESS 21 0.0008
276 WALKING AID USER 5 0.0008
277 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
278 BRONCHITIS 56 0.0008
279 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
280 FOOD POISONING 4 0.0007
281 NEUROTOXICITY 13 0.0007
282 INJURY 52 0.0007
283 CHEILITIS 4 0.0007
284 SPUTUM DISCOLOURED 7 0.0007
285 NORMAL NEWBORN 4 0.0007
286 HYDROCEPHALUS 4 0.0007
287 ABNORMAL LOSS OF WEIGHT 5 0.0007
288 NONSPECIFIC REACTION 4 0.0007
289 LACRIMATION INCREASED 22 0.0007
290 DENTAL CARIES 8 0.0007
291 GASTRIC ULCER HAEMORRHAGE 4 0.0007
292 FUNGAL INFECTION 24 0.0007
293 EOSINOPHIL COUNT INCREASED 6 0.0007
294 TOOTHACHE 13 0.0007
295 ATRIAL SEPTAL DEFECT 6 0.0007
296 DERMATITIS 15 0.0007
297 MASS 10 0.0007
298 MALNUTRITION 8 0.0007
299 SENSATION OF FOREIGN BODY 6 0.0007
300 GASTROOESOPHAGEAL REFLUX DISEASE 57 0.0007
301 HAEMATOCRIT DECREASED 14 0.0007
302 CHOLECYSTITIS ACUTE 4 0.0007
303 DIALYSIS 10 0.0007
304 SINUS TACHYCARDIA 10 0.0007
305 MYOCARDIAL ISCHAEMIA 8 0.0007
306 NEUROLOGICAL SYMPTOM 4 0.0007
307 VENTRICULAR SEPTAL DEFECT 4 0.0007
308 HYPERTONIA 4 0.0007
309 BACTERIAL INFECTION 13 0.0007
310 EXERCISE TOLERANCE DECREASED 4 0.0007
311 PNEUMOTHORAX 11 0.0007
312 BLOOD SODIUM DECREASED 13 0.0007
313 EYELID PTOSIS 7 0.0007
314 CARDIOMYOPATHY 10 0.0007
315 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
316 SINUS HEADACHE 4 0.0007
317 FACIAL PAIN 6 0.0007
318 RESPIRATORY FAILURE 49 0.0007
319 TENDERNESS 7 0.0007
320 HYDRONEPHROSIS 5 0.0007
321 ANAL INCONTINENCE 6 0.0007
322 PSYCHOMOTOR HYPERACTIVITY 11 0.0007
323 OSTEOMYELITIS 12 0.0007
324 BLOOD UREA INCREASED 11 0.0007
325 BODY HEIGHT DECREASED 7 0.0007
326 SEPSIS 73 0.0007
327 PROCEDURAL COMPLICATION 5 0.0007
328 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
329 ENCEPHALOPATHY 16 0.0007
330 RENAL FAILURE CHRONIC 5 0.0006
331 IRON DEFICIENCY ANAEMIA 6 0.0006
332 DECREASED ACTIVITY 7 0.0006
333 FOOD ALLERGY 5 0.0006
334 HAEMOPTYSIS 18 0.0006
335 OLIGURIA 4 0.0006
336 ERYTHEMA MULTIFORME 6 0.0006
337 HYPOALBUMINAEMIA 5 0.0006
338 CARPAL TUNNEL SYNDROME 9 0.0006
339 HAEMATURIA 22 0.0006
340 LACERATION 6 0.0006
341 SWELLING OF EYELID 4 0.0006
342 GASTROINTESTINAL PAIN 7 0.0006
343 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
344 PAIN IN JAW 18 0.0006
345 MULTIPLE INJURIES 4 0.0006
346 TOOTH FRACTURE 7 0.0006
347 RESPIRATORY TRACT CONGESTION 10 0.0006
348 URINARY RETENTION 21 0.0006
349 SUBDURAL HAEMATOMA 9 0.0006
350 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
351 ANOSMIA 9 0.0006
352 UNEVALUABLE EVENT 47 0.0006
353 ANOREXIA 8 0.0006
354 UNRESPONSIVE TO STIMULI 16 0.0006
355 FLUID OVERLOAD 9 0.0006
356 NEURALGIA 15 0.0006
357 BLOOD POTASSIUM INCREASED 10 0.0006
358 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
359 PULMONARY CONGESTION 8 0.0006
360 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
361 BONE DISORDER 11 0.0006
362 FEBRILE NEUTROPENIA 40 0.0006
363 EMBOLISM 5 0.0006
364 RENAL FAILURE ACUTE 25 0.0006
365 SUBARACHNOID HAEMORRHAGE 6 0.0006
366 DRUG EXPOSURE DURING PREGNANCY 20 0.0006
367 VITAMIN D DECREASED 5 0.0006
368 TOOTH DISORDER 13 0.0006
369 SCAR 10 0.0006
370 ANURIA 5 0.0006
371 RESPIRATION ABNORMAL 4 0.0006
372 SKIN ULCER 15 0.0006
373 JOINT EFFUSION 4 0.0006
374 SNEEZING 13 0.0006
375 CHOLELITHIASIS 19 0.0006
376 DROOLING 4 0.0006
377 LYMPHOEDEMA 4 0.0006
378 VENTRICULAR EXTRASYSTOLES 6 0.0006
379 PYELONEPHRITIS 5 0.0006
380 BURSITIS 7 0.0006
381 PULMONARY HYPERTENSION 12 0.0006
382 ACUTE KIDNEY INJURY 88 0.0006
383 LOCAL SWELLING 10 0.0006
384 TRANSFUSION 6 0.0006
385 GASTRITIS 15 0.0006
386 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
387 APPLICATION SITE REACTION 4 0.0006
388 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
389 IMMUNOSUPPRESSION 5 0.0006
390 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
391 ABSCESS 9 0.0006
392 CYST 7 0.0006
393 HAEMORRHOIDS 11 0.0006
394 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
395 OSTEOPOROSIS 23 0.0006
396 PLEURAL EFFUSION 34 0.0006
397 NEUROPATHY PERIPHERAL 53 0.0006
398 BEHAVIOUR DISORDER 3 0.0006
399 DRUG ADMINISTRATION ERROR 17 0.0006
400 MUSCLE ATROPHY 7 0.0006
401 BIPOLAR DISORDER 6 0.0006
402 ASPIRATION 6 0.0005
403 EXOSTOSIS 5 0.0005
404 MYDRIASIS 7 0.0005
405 ROTATOR CUFF SYNDROME 7 0.0005
406 STOMATITIS 33 0.0005
407 ANAPHYLACTIC REACTION 30 0.0005
408 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
409 SENSITIVE SKIN 4 0.0005
410 GRAND MAL CONVULSION 5 0.0005
411 VENTRICULAR FIBRILLATION 6 0.0005
412 ARTHROPOD BITE 4 0.0005
413 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
414 PERSONALITY CHANGE 5 0.0005
415 SINUSITIS 55 0.0005
416 WOUND 15 0.0005
417 DEFORMITY 5 0.0005
418 OXYGEN SATURATION DECREASED 30 0.0005
419 INCORRECT DRUG ADMINISTRATION DURATION 15 0.0005
420 CEREBRAL INFARCTION 13 0.0005
421 METABOLIC ACIDOSIS 17 0.0005
422 CHROMATURIA 12 0.0005
423 HEART RATE IRREGULAR 12 0.0005
424 MITRAL VALVE INCOMPETENCE 6 0.0005
425 APHASIA 16 0.0005
426 APPLICATION SITE PRURITUS 12 0.0005
427 GASTRIC ULCER 10 0.0005
428 SCAB 6 0.0005
429 TROPONIN INCREASED 4 0.0005
430 CHOLECYSTECTOMY 6 0.0005
431 HAEMODYNAMIC INSTABILITY 4 0.0005
432 PRODUCTIVE COUGH 25 0.0005
433 MUSCULOSKELETAL DISCOMFORT 9 0.0005
434 MOUTH ULCERATION 11 0.0005
435 POST PROCEDURAL COMPLICATION 10 0.0005
436 IMPAIRED HEALING 17 0.0005
437 ORTHOSTATIC HYPOTENSION 9 0.0005
438 ANKLE FRACTURE 8 0.0005
439 DYSURIA 19 0.0005
440 URINARY TRACT INFECTION 88 0.0005
441 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
442 EMOTIONAL DISTRESS 62 0.0005
443 GASTROINTESTINAL INFLAMMATION 4 0.0005
444 ASCITES 15 0.0005
445 HEPATOMEGALY 5 0.0005
446 DRUG ERUPTION 9 0.0005
447 URINARY INCONTINENCE 15 0.0005
448 HEAD INJURY 16 0.0005
449 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
450 OBESITY 8 0.0005
451 ERYTHEMA 103 0.0005
452 BRAIN INJURY 5 0.0005
453 EMPHYSEMA 5 0.0005
454 OSTEOARTHRITIS 21 0.0005
455 DRY THROAT 5 0.0005
456 MOTOR DYSFUNCTION 5 0.0005
457 CYTOPENIA 6 0.0005
458 POLYURIA 4 0.0005
459 NEUTROPHIL COUNT INCREASED 5 0.0005
460 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
461 EAR DISCOMFORT 5 0.0005
462 CARDIAC FAILURE CONGESTIVE 39 0.0005
463 VENTRICULAR TACHYCARDIA 8 0.0005
464 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
465 ABNORMAL BEHAVIOUR 19 0.0005
466 DYSSTASIA 14 0.0005
467 LIMB INJURY 13 0.0005
468 UNINTENDED PREGNANCY 5 0.0005
469 INTENTIONAL DRUG MISUSE 10 0.0005
470 DYSPNOEA EXERTIONAL 18 0.0005
471 FOLLICULITIS 5 0.0005
472 PERICARDIAL EFFUSION 11 0.0005
473 TYPE 2 DIABETES MELLITUS 16 0.0005
474 ACNE 36 0.0005
475 CONVULSION 27 0.0005
476 DIVERTICULITIS 13 0.0005
477 HYPERGLYCAEMIA 17 0.0005
478 HYPOAESTHESIA ORAL 7 0.0005
479 DEEP VEIN THROMBOSIS 30 0.0005
480 SKIN SWELLING 4 0.0005
481 SWELLING FACE 30 0.0005
482 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
483 LOCALISED INFECTION 11 0.0005
484 TUMOUR LYSIS SYNDROME 4 0.0005
485 SINUS DISORDER 9 0.0005
486 EAR INFECTION 12 0.0005
487 WRONG DRUG ADMINISTERED 4 0.0004
488 BASAL CELL CARCINOMA 7 0.0004
489 GALLBLADDER DISORDER 8 0.0004
490 MENSTRUATION IRREGULAR 12 0.0004
491 QUALITY OF LIFE DECREASED 6 0.0004
492 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
493 NEPHROPATHY TOXIC 5 0.0004
494 OSTEONECROSIS OF JAW 11 0.0004
495 BLOOD BILIRUBIN INCREASED 12 0.0004
496 ANXIETY 126 0.0004
497 OEDEMA 24 0.0004
498 DRUG TOXICITY 6 0.0004
499 RENAL IMPAIRMENT 37 0.0004
500 PNEUMONIA ASPIRATION 11 0.0004
501 MICTURITION URGENCY 5 0.0004
502 BRADYCARDIA 23 0.0004
503 NERVE COMPRESSION 4 0.0004
504 METASTASES TO LUNG 5 0.0004
505 DYSPHAGIA 41 0.0004
506 ELECTROLYTE IMBALANCE 5 0.0004
507 THINKING ABNORMAL 8 0.0004
508 CORONARY ARTERY DISEASE 13 0.0004
509 APPENDICITIS 4 0.0004
510 DEHYDRATION 57 0.0004
511 PULMONARY OEDEMA 19 0.0004
512 WHEEZING 25 0.0004
513 INFECTION 61 0.0004
514 COAGULOPATHY 7 0.0004
515 MYOCLONUS 5 0.0004
516 CARDIOGENIC SHOCK 6 0.0004
517 LOWER LIMB FRACTURE 8 0.0004
518 SINUS BRADYCARDIA 4 0.0004
519 HYPOKINESIA 6 0.0004
520 HEMIPARESIS 7 0.0004
521 HYPERTENSION 87 0.0004
522 VITAMIN D DEFICIENCY 4 0.0004
523 CHOKING 8 0.0004
524 NO THERAPEUTIC RESPONSE 5 0.0004
525 APPLICATION SITE PAIN 9 0.0004
526 GASTRIC DISORDER 14 0.0004
527 THERAPY CHANGE 4 0.0004
528 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
529 BLOOD PRESSURE DECREASED 27 0.0004
530 ABASIA 10 0.0004
531 PNEUMONIA 131 0.0004
532 DISABILITY 8 0.0004
533 LIGAMENT SPRAIN 4 0.0004
534 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
535 IMMUNODEFICIENCY 6 0.0004
536 BLOOD PRESSURE ABNORMAL 8 0.0004
537 ILEUS 5 0.0004
538 RHINORRHOEA 26 0.0004
539 NERVOUSNESS 21 0.0004
540 APPLICATION SITE IRRITATION 5 0.0004
541 RASH 175 0.0004
542 SKIN LESION 11 0.0004
543 HYPOTONIA 4 0.0004
544 DRY EYE 20 0.0004
545 COUGH 112 0.0004
546 SECRETION DISCHARGE 5 0.0004
547 BONE LOSS 6 0.0004
548 HYPOTENSION 80 0.0004
549 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
550 RECTAL HAEMORRHAGE 17 0.0004
551 PLATELET COUNT DECREASED 42 0.0004
552 OEDEMA PERIPHERAL 48 0.0004
553 DYSPHONIA 23 0.0004
554 ANAEMIA 75 0.0004
555 PYREXIA 136 0.0004
556 SKIN IRRITATION 18 0.0004
557 NASAL CONGESTION 23 0.0004
558 VISUAL ACUITY REDUCED 13 0.0004
559 MUSCLE TWITCHING 9 0.0004
560 LIP SWELLING 13 0.0004
561 HYPOKALAEMIA 18 0.0004
562 RIB FRACTURE 8 0.0004
563 HYPERSENSITIVITY 72 0.0004
564 TEMPERATURE INTOLERANCE 4 0.0004
565 CARDIAC ARREST 32 0.0004
566 CATARACT 23 0.0004
567 LUNG INFECTION 6 0.0004
568 RASH GENERALISED 10 0.0004
569 HYPERBILIRUBINAEMIA 4 0.0004
570 HAEMATOMA 10 0.0004
571 CRYING 14 0.0004
572 BURNING SENSATION 27 0.0004
573 RESTLESS LEGS SYNDROME 7 0.0004
574 RED BLOOD CELL COUNT DECREASED 11 0.0004
575 RESPIRATORY TRACT INFECTION 10 0.0004
576 APPLICATION SITE ERYTHEMA 10 0.0004
577 CYANOSIS 6 0.0004
578 PRODUCT USE COMPLAINT 6 0.0004
579 TOOTH INFECTION 5 0.0004
580 SCRATCH 4 0.0004
581 HALLUCINATION, VISUAL 8 0.0004
582 DISORIENTATION 15 0.0004
583 CONJUNCTIVITIS 7 0.0004
584 CYSTITIS 12 0.0004
585 ATRIAL FLUTTER 3 0.0004
586 HYPOTHYROIDISM 12 0.0004
587 BONE PAIN 22 0.0004
588 DELIRIUM 13 0.0004
589 MALIGNANT MELANOMA 5 0.0004
590 DYSARTHRIA 14 0.0004
591 RASH MACULAR 13 0.0004
592 VISION BLURRED 51 0.0004
593 CONSTIPATION 81 0.0004
594 PAIN OF SKIN 10 0.0004
595 MENTAL IMPAIRMENT 9 0.0004
596 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
597 SINUS CONGESTION 5 0.0004
598 PHARYNGITIS STREPTOCOCCAL 4 0.0004
599 RESPIRATORY DISORDER 11 0.0004
600 MENTAL DISORDER 16 0.0004
601 BLOOD CREATININE INCREASED 24 0.0004
602 LYMPHADENOPATHY 13 0.0004
603 PULMONARY THROMBOSIS 4 0.0004
604 ACUTE HEPATIC FAILURE 5 0.0004
605 METASTASES TO BONE 6 0.0004
606 EYE DISORDER 12 0.0004
607 MANIA 6 0.0004
608 HEART RATE INCREASED 36 0.0004
609 SWELLING 34 0.0004
610 ILL-DEFINED DISORDER 22 0.0004
611 EPISTAXIS 27 0.0004
612 AGEUSIA 9 0.0004
613 PRODUCT QUALITY ISSUE 49 0.0004
614 VIRAL INFECTION 12 0.0004
615 SKIN DISORDER 12 0.0004
616 NERVE INJURY 4 0.0004
617 DEPRESSED MOOD 19 0.0004
618 APHONIA 5 0.0004
619 ORAL PAIN 8 0.0004
620 EMOTIONAL DISORDER 11 0.0004
621 OCULAR DISCOMFORT 4 0.0004
622 FISTULA 4 0.0004
623 RESTLESSNESS 13 0.0004
624 METRORRHAGIA 6 0.0004
625 BONE DENSITY DECREASED 11 0.0004
626 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
627 SYNCOPE 35 0.0003
628 TREMOR 58 0.0003
629 CYTOKINE RELEASE SYNDROME 7 0.0003
630 TINNITUS 16 0.0003
631 SKIN DISCOLOURATION 16 0.0003
632 PARANOIA 6 0.0003
633 IMPAIRED QUALITY OF LIFE 5 0.0003
634 BALANCE DISORDER 30 0.0003
635 PARAESTHESIA ORAL 5 0.0003
636 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
637 SEPTIC SHOCK 15 0.0003
638 DYSKINESIA 14 0.0003
639 DISCOMFORT 21 0.0003
640 POST PROCEDURAL HAEMORRHAGE 4 0.0003
641 BLINDNESS 14 0.0003
642 CAESAREAN SECTION 4 0.0003
643 MUSCULAR WEAKNESS 39 0.0003
644 APATHY 5 0.0003
645 AMENORRHOEA 6 0.0003
646 METASTASES TO LIVER 6 0.0003
647 SEXUAL DYSFUNCTION 4 0.0003
648 AGITATION 25 0.0003
649 LYMPHOCYTE COUNT DECREASED 6 0.0003
650 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
651 COVID-19 PNEUMONIA 4 0.0003
652 TOOTH LOSS 7 0.0003
653 DRY SKIN 45 0.0003
654 POLLAKIURIA 14 0.0003
655 CEREBRAL HAEMORRHAGE 12 0.0003
656 MACULAR DEGENERATION 4 0.0003
657 OSTEONECROSIS 11 0.0003
658 CHILLS 39 0.0003
659 RASH PRURITIC 18 0.0003
660 EXPIRED PRODUCT ADMINISTERED 11 0.0003
661 FALL 110 0.0003
662 LETHARGY 19 0.0003
663 NOCTURIA 4 0.0003
664 RETCHING 7 0.0003
665 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
666 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
667 SKIN CANCER 7 0.0003
668 SPEECH DISORDER 17 0.0003
669 FEELING COLD 9 0.0003
670 TENDONITIS 5 0.0003
671 FEMUR FRACTURE 10 0.0003
672 HEPATIC STEATOSIS 6 0.0003
673 NECK PAIN 18 0.0003
674 TOOTH EXTRACTION 4 0.0003
675 SKIN EXFOLIATION 27 0.0003
676 PAIN 196 0.0003
677 DERMATITIS ALLERGIC 4 0.0003
678 HYPOCALCAEMIA 6 0.0003
679 FOOT FRACTURE 6 0.0003
680 DEPRESSION 72 0.0003
681 DYSPNOEA 179 0.0003
682 BLOOD URINE PRESENT 6 0.0003
683 ULCER 5 0.0003
684 HYPERSOMNIA 9 0.0003
685 THROMBOCYTOPENIA 35 0.0003
686 RASH PAPULAR 7 0.0003
687 HAEMOGLOBIN DECREASED 32 0.0003
688 GLAUCOMA 6 0.0003
689 INFUSION SITE PAIN 4 0.0003
690 ANAPHYLACTIC SHOCK 8 0.0003
691 CONFUSIONAL STATE 50 0.0003
692 RHEUMATOID ARTHRITIS 35 0.0003
693 AUTOIMMUNE DISORDER 3 0.0003
694 JOINT SWELLING 37 0.0003
695 NODULE 4 0.0003
696 ACUTE MYOCARDIAL INFARCTION 9 0.0003
697 FLUSHING 31 0.0003
698 BEDRIDDEN 4 0.0003
699 CHEST DISCOMFORT 31 0.0003
700 CONTUSION 29 0.0003
701 PREGNANCY 6 0.0003
702 JAUNDICE 8 0.0003
703 DISTURBANCE IN ATTENTION 16 0.0003
704 LOSS OF CONSCIOUSNESS 38 0.0003
705 HAEMORRHAGE 31 0.0003
706 DYSGEUSIA 22 0.0003
707 CANDIDA INFECTION 5 0.0003
708 FEEDING DISORDER 6 0.0003
709 HEPATIC FUNCTION ABNORMAL 11 0.0003
710 COMA 14 0.0003
711 TREATMENT NONCOMPLIANCE 16 0.0003
712 CORONARY ARTERY OCCLUSION 4 0.0003
713 OROPHARYNGEAL PAIN 27 0.0003
714 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
715 THROAT IRRITATION 13 0.0003
716 ABNORMAL DREAMS 8 0.0003
717 ORAL DISCOMFORT 4 0.0003
718 ATRIAL FIBRILLATION 28 0.0003
719 HYPOMAGNESAEMIA 4 0.0003
720 ASTHENIA 108 0.0003
721 COORDINATION ABNORMAL 4 0.0003
722 PARAESTHESIA 45 0.0003
723 HYPERKALAEMIA 10 0.0003
724 DIARRHOEA 184 0.0003
725 SKIN REACTION 4 0.0003
726 COLD SWEAT 5 0.0003
727 DRY MOUTH 23 0.0003
728 NEPHROLITHIASIS 13 0.0003
729 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
730 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
731 JOINT INJURY 6 0.0003
732 BRONCHOSPASM 4 0.0003
733 AGGRESSION 14 0.0003
734 ABDOMINAL PAIN 65 0.0003
735 SKIN BURNING SENSATION 20 0.0003
736 HALLUCINATION 21 0.0003
737 VOMITING 131 0.0003
738 GASTROENTERITIS VIRAL 5 0.0003
739 ABDOMINAL PAIN LOWER 7 0.0003
740 WHITE BLOOD CELL COUNT DECREASED 30 0.0003
741 HYPERTHYROIDISM 4 0.0003
742 BACK INJURY 3 0.0003
743 PULMONARY EMBOLISM 26 0.0003
744 WEIGHT DECREASED 76 0.0003
745 GAIT DISTURBANCE 52 0.0003
746 INFLAMMATION 14 0.0003
747 ANGIOEDEMA 12 0.0003
748 TACHYCARDIA 24 0.0003
749 TRANSAMINASES INCREASED 6 0.0003
750 HEPATOTOXICITY 6 0.0003
751 DIZZINESS 134 0.0003
752 ABDOMINAL DISTENSION 28 0.0003
753 HYPOGLYCAEMIA 13 0.0003
754 GLOSSODYNIA 6 0.0003
755 BLISTER 15 0.0003
756 DECREASED APPETITE 62 0.0003
757 BACK PAIN 62 0.0003
758 INSOMNIA 71 0.0003
759 NASOPHARYNGITIS 49 0.0003
760 MUSCULOSKELETAL DISORDER 5 0.0003
761 FEELING JITTERY 5 0.0003
762 MEMORY IMPAIRMENT 36 0.0003
763 AMNESIA 17 0.0003
764 SHOCK 6 0.0003
765 HYPOAESTHESIA 39 0.0003
766 NIGHTMARE 9 0.0003
767 PHARYNGEAL OEDEMA 4 0.0003
768 THYROID DISORDER 4 0.0003
769 RENAL DISORDER 12 0.0003
770 DELUSION 4 0.0003
771 EJECTION FRACTION DECREASED 4 0.0003
772 SURGERY 15 0.0003
773 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
774 INFLUENZA 28 0.0003
775 RASH ERYTHEMATOUS 12 0.0003
776 MUSCLE SPASMS 46 0.0003
777 BLOOD PRESSURE FLUCTUATION 6 0.0002
778 BLOOD GLUCOSE INCREASED 47 0.0002
779 IRRITABILITY 15 0.0002
780 NIGHT SWEATS 8 0.0002
781 MYALGIA 42 0.0002
782 PRESYNCOPE 6 0.0002
783 BACK DISORDER 4 0.0002
784 PANCREATITIS 13 0.0002
785 NAUSEA 194 0.0002
786 FEELING HOT 15 0.0002
787 ANGINA PECTORIS 7 0.0002
788 MULTIPLE FRACTURES 4 0.0002
789 CHEST PAIN 45 0.0002
790 SEIZURE 28 0.0002
791 DRUG LEVEL INCREASED 4 0.0002
792 HYPERHIDROSIS 31 0.0002
793 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
794 ASTHMA 27 0.0002
795 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
796 FACE OEDEMA 4 0.0002
797 PSYCHOTIC DISORDER 7 0.0002
798 ANGER 8 0.0002
799 DIABETES MELLITUS 18 0.0002
800 BLOOD CHOLESTEROL INCREASED 11 0.0002
801 NEUTROPENIA 32 0.0002
802 CIRCULATORY COLLAPSE 4 0.0002
803 GASTROINTESTINAL DISORDER 21 0.0002
804 DYSPEPSIA 23 0.0002
805 FEELING ABNORMAL 56 0.0002
806 ERECTILE DYSFUNCTION 6 0.0002
807 DRUG RESISTANCE 6 0.0002
808 IRRITABLE BOWEL SYNDROME 5 0.0002
809 LIVER FUNCTION TEST INCREASED 5 0.0002
810 PRURITUS GENERALISED 5 0.0002
811 DEAFNESS 6 0.0002
812 MUCOSAL INFLAMMATION 6 0.0002
813 ALOPECIA 45 0.0002
814 SEDATION 6 0.0002
815 BLOOD GLUCOSE DECREASED 11 0.0002
816 ARTHRITIS 18 0.0002
817 SOMNOLENCE 46 0.0002
818 ABDOMINAL PAIN UPPER 47 0.0002
819 ADVERSE REACTION 3 0.0002
820 RASH MACULO-PAPULAR 5 0.0002
821 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
822 THROAT TIGHTNESS 6 0.0002
823 PRURITUS 85 0.0002
824 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
825 PELVIC PAIN 4 0.0002
826 MOOD ALTERED 6 0.0002
827 SUICIDAL IDEATION 20 0.0002
828 VISUAL IMPAIRMENT 27 0.0002
829 BLOOD GLUCOSE ABNORMAL 4 0.0002
830 FLUID RETENTION 11 0.0002
831 ROAD TRAFFIC ACCIDENT 9 0.0002
832 DRUG INTERACTION 34 0.0002
833 BLINDNESS UNILATERAL 3 0.0002
834 CARDIAC FAILURE 17 0.0002
835 FRACTURE 4 0.0002
836 PROTEINURIA 4 0.0002
837 FATIGUE 163 0.0002
838 BLOOD PRESSURE INCREASED 32 0.0002
839 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
840 HERPES ZOSTER 12 0.0002
841 MALAISE 91 0.0002
842 VAGINAL HAEMORRHAGE 9 0.0002
843 CONDITION AGGRAVATED 63 0.0002
844 HEADACHE 129 0.0002
845 FIBROMYALGIA 5 0.0002
846 ORAL HERPES 4 0.0002
847 SKIN FISSURES 4 0.0002
848 URTICARIA 34 0.0002
849 DISEASE PROGRESSION 24 0.0002
850 MYOCARDIAL INFARCTION 35 0.0002
851 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
852 SPINAL FRACTURE 4 0.0002
853 ARTHRALGIA 83 0.0002
854 HEART RATE DECREASED 7 0.0002
855 PREMATURE BABY 6 0.0002
856 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
857 FULL BLOOD COUNT DECREASED 4 0.0002
858 ARTHROPATHY 11 0.0002
859 TASTE DISORDER 4 0.0002
860 BONE MARROW FAILURE 4 0.0002
861 PANCYTOPENIA 11 0.0002
862 BODY TEMPERATURE INCREASED 4 0.0002
863 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
864 HEPATITIS 5 0.0002
865 HYPONATRAEMIA 11 0.0002
866 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
867 MUSCULOSKELETAL STIFFNESS 17 0.0002
868 DIPLOPIA 5 0.0002
869 ACUTE MYELOID LEUKAEMIA 3 0.0002
870 CARDIAC DISORDER 18 0.0002
871 PANIC ATTACK 7 0.0002
872 ECZEMA 10 0.0002
873 MUSCULOSKELETAL PAIN 10 0.0002
874 EATING DISORDER 4 0.0002
875 PALPITATIONS 22 0.0002
876 IMPAIRED WORK ABILITY 4 0.0002
877 PAIN IN EXTREMITY 55 0.0002
878 FREQUENT BOWEL MOVEMENTS 5 0.0002
879 ABDOMINAL DISCOMFORT 31 0.0002
880 SLEEP DISORDER 13 0.0002
881 PNEUMONITIS 5 0.0002
882 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
883 WEIGHT INCREASED 41 0.0002
884 DRUG DOSE OMISSION 30 0.0002
885 PROCEDURAL PAIN 5 0.0002
886 DEMENTIA 5 0.0002
887 ADVERSE DRUG REACTION 16 0.0002
888 PANCREATITIS ACUTE 4 0.0002
889 TARDIVE DYSKINESIA 5 0.0002
890 FLATULENCE 10 0.0002
891 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
893 COGNITIVE DISORDER 8 0.0002
894 DRUG INEFFECTIVE 225 0.0002
895 TREATMENT FAILURE 14 0.0002
896 MIGRAINE 16 0.0002
897 WITHDRAWAL SYNDROME 7 0.0002
898 PRODUCT USE ISSUE 31 0.0002
899 THERAPEUTIC RESPONSE DECREASED 10 0.0002
900 C-REACTIVE PROTEIN INCREASED 6 0.0002
901 UNDERDOSE 12 0.0002
902 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
903 LUNG DISORDER 8 0.0002
904 HAEMATOCHEZIA 9 0.0002
905 HYPOACUSIS 7 0.0002
906 THROMBOSIS 13 0.0002
907 HEPATIC ENZYME INCREASED 11 0.0002
908 SWOLLEN TONGUE 5 0.0002
909 INTESTINAL OBSTRUCTION 6 0.0002
910 OFF LABEL USE 139 0.0002
911 HAEMATEMESIS 4 0.0002
912 COLITIS ULCERATIVE 7 0.0002
913 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
914 THERAPY NON-RESPONDER 7 0.0002
915 MOVEMENT DISORDER 5 0.0002
916 CEREBROVASCULAR ACCIDENT 26 0.0002
917 JOINT STIFFNESS 4 0.0002
918 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
919 ABORTION SPONTANEOUS 6 0.0001
920 HOSPITALISATION 23 0.0001
921 PSORIATIC ARTHROPATHY 6 0.0001
922 ARRHYTHMIA 7 0.0001
923 PALLOR 4 0.0001
924 MULTIPLE SCLEROSIS 7 0.0001
925 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
926 ILLNESS 15 0.0001
927 CARDIO-RESPIRATORY ARREST 6 0.0001
928 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
929 LEUKOPENIA 7 0.0001
930 MOBILITY DECREASED 10 0.0001
931 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
932 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
933 LABORATORY TEST ABNORMAL 4 0.0001
934 LIVER DISORDER 6 0.0001
935 NEOPLASM MALIGNANT 9 0.0001
936 HEPATIC FAILURE 4 0.0001
937 SUICIDE ATTEMPT 8 0.0001
938 COLITIS 5 0.0001
939 OVERDOSE 28 0.0001
940 GYNAECOMASTIA 4 0.0001
941 LIMB DISCOMFORT 4 0.0001
942 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
943 NERVOUS SYSTEM DISORDER 4 0.0001
944 HIP FRACTURE 4 0.0001
945 PERIPHERAL SWELLING 19 0.0001
946 NEUTROPHIL COUNT DECREASED 5 0.0001
947 INTENTIONAL PRODUCT MISUSE 10 0.0001
948 COVID-19 20 0.0001
949 DEATH 98 0.0001
950 TOXICITY TO VARIOUS AGENTS 19 0.0001
951 EXPOSURE DURING PREGNANCY 7 0.0001
952 PRODUCT DOSE OMISSION ISSUE 33 0.0001
953 PRODUCT ADHESION ISSUE 4 0.0001
954 DRUG EFFECT DECREASED 6 0.0001
955 DRUG EFFECT INCOMPLETE 4 0.0001
956 ACCIDENTAL OVERDOSE 4 0.0001
957 INFLUENZA LIKE ILLNESS 9 0.0001
958 INTENTIONAL OVERDOSE 7 0.0001
959 ADVERSE EVENT 10 0.0001
960 MEDICATION ERROR 6 0.0001
961 HOT FLUSH 8 0.0001
962 INFUSION RELATED REACTION 7 0.0001
963 INTERSTITIAL LUNG DISEASE 5 0.0001
964 PLASMA CELL MYELOMA 4 0.0001
965 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
966 DEVICE BREAKAGE 4 0.0001
967 VERTIGO 6 0.0001
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
969 LUNG NEOPLASM MALIGNANT 4 0.0001
970 BREAST CANCER 9 0.0001
971 RHABDOMYOLYSIS 4 0.0001
972 INJECTION SITE BRUISING 7 0.0001
973 INCORRECT DOSE ADMINISTERED 20 0.0001
974 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
975 INJECTION SITE REACTION 6 0.0001
976 DEVICE MALFUNCTION 6 0.0001
977 PSORIASIS 11 0.0001
978 INJECTION SITE ERYTHEMA 10 0.0001
979 DRUG WITHDRAWAL SYNDROME 7 0.0001
980 THERAPY CESSATION 4 0.0001
981 DRUG INTOLERANCE 7 0.0001
982 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
984 DEVICE ISSUE 6 0.0001
985 PRODUCT DOSE OMISSION 4 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
987 THERAPY INTERRUPTED 4 0.0001
988 INJECTION SITE PAIN 17 0.0001
989 INJECTION SITE HAEMORRHAGE 4 0.0001
990 NO ADVERSE EVENT 8 0.0000
991 DRUG DEPENDENCE 5 0.0000